95MO Circulating tumor DNA (ctDNA) dynamics in patients (pts) receiving capecitabine (CAPE) for early-stage triple-negative breast cancer (eTNBC) with an incomplete response to neoadjuvant therapy (NAT)
Autor: | Gupta, T., Garcia, C., Biederman, S., Kalashnikova, E., Rodriguez, A.A., Liu, M.C., Keenan, J., Medford, A.J., Isakoff, S., Bardia, A., Telli, M.L., Ho, A.Y. |
---|---|
Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
Databáze: | ScienceDirect |
Externí odkaz: |